No Data
No Data
Memphasys Acting CEO Transitions to Permanent Role
Reproductive biotechnology company Memphasys (ASX:MEM) appointed acting Chief Executive Officer David Ali to a permanent role on a full-time basis, effective July 1, according to a Thursday filing wit
Memphasys Ltd Announces Unquoted Options Issue
Memphasys Ltd Expands Market Offerings
Memphasys Ltd Issues New Employee Incentive Options
Memphasys Appoints Consultant to Help Develop Animal Breeding Devices
Memphasys (ASX:MEM) appointed consultant Klean Gene to help advance the development of the fertility firm's range of animal breeding devices, according to a Thursday filing with the Australian bourse.
Memphasys Ltd Advances IVF With Speedy Felix System
No Data